We harness ground-breaking science with innovative technology to create solutions that provide a great user experience for patients, physicians and governing bodies alike, leading ultimately to the transformation of the healthcare industry.
The current development of our patent pending diagnostic testing kit for Covid-19 (Project Gumnuts) provides an easy and effective way that enables people to obtain the information they need and require. Complemented by our mobile check-in app (Teman Sehat), we empower users to manage their diagnostic experiences on their own terms, safeguard their privacy, share experiences, obtain passport verification and find community.
Achiko holds exclusive commercialisation rights to the technology underlying Project Gumnuts from Regenacellex.SL. It may be used to detect all types of Covid-19, but also many other pathogens. Achiko is looking forward to the completion of regulatory approval and getting the technology to market as quickly as possible, applying it in an array of test kits and other assay formats.
Headquartered in Zurich, we have offices in Hong Kong, Jakarta, Singapore
and Seoul.
http://www.achiko.com
About Regenacellx.sl
We are a regenerative medicine company working with expert clinicians and
scientists in the field of stem cells and small chemicals to advance cell
replacement strategies to regenerate damaged tissues of the human body. In
response to the global Covid-19 pandemic, we are developing next stage
technology in the testing and diagnosis of pathogens as simple kits for home
use or point of care (PoC) for a range of human diseases including Covid-19.
Disclaimer
This communication expressly or implicitly contains certain forward-looking
statements concerning Achiko AG and its business. Such statements involve certain
known and unknown risks, uncertainties and other factors, which could cause the
actual results, financial condition, performance or achievements of Achiko AG
to be materially different from any future results, performance or achievements
expressed or implied by such forward-looking statements. Achiko AG is providing
this communication as of this date and does not undertake to update any
forward-looking statements contained herein as a result of new information,
future events or otherwise.